Gillings leader helps write ASPPH global health criteria
August 23, 2018 Dr. Peggy Bentley of the Gillings School co-chaired the ASPPH committee responsible for the newly released global health competencies for Master of Public Health degrees.
New study finds fake, low-quality medicines prevalent in the developing world
August 12, 2018 A new study by Drs. Sachiko Ozawa and James Herrington, and colleagues, found that substandard and falsified medicines, including medicines to treat malaria, are a serious problem in much of the world. In low- and middle-income countries, more than 13 percent of the essential medicines that satisfy the priority health care needs of the population fall in this category. Map design by UNC Eshelman School of Pharmacy.
Gillings School researcher addresses incentive disparities in HIV research
August 8, 2018 Dr. Karine Dubé shares new research into the ethics of incentives. She and her co-authors advocate for additional guidance on payments in clinical research and promote the idea of creating a database of payment practices specific to HIV research.
Curtis co-authored award-winning report about programs integrating HIV, TB care in Ukraine
July 28, 2018 Dr. Sian Curtis is co-author of a MEASURE Evaluation report about programs integrating HIV and tuberculosis care in Ukraine. An abstract of the report won a top prize at the International AIDS Society annual conference in Amsterdam.
Researchers conduct most diverse genetic study of female reproductive milestones to date
July 25, 2018 A new study is the first to examine multiple genes that influence the age at which a woman starts her period and experiences menopause among a large sample of United States women of diverse ancestries. The findings highlight the benefits of including diverse populations in studies of the genetics of female growth and development.
HPV screening found more effective than Pap test at identifying cervical cancer
July 25, 2018 Cervical cancer screening with cytology – commonly known as a Pap test – is one of the most widely used cancer control interventions in high-income settings. A recent study demonstrated, however, that HPV testing detects cervical dysplasia earlier and more accurately than cytology.
Gillings researchers fight emerging diseases
July 5, 2018 Utilizing the expertise of the Baric Lab at the UNC Gillings School, Gilead Sciences is making breakthroughs in developing drugs to fight some of the world’s deadliest viruses. The Gilead broad-spectrum treatment that was tested and proven in the Baric Lab, now known as Remdesivir, was deployed for use in the Ebola outbreak in the Democratic Republic of the Congo.
Study clarifies how genetic variants linked with African ancestry impact heart disease
July 3, 2018 A recent study co-authored by researchers in the Gillings School examined APOL1 genotypes, which are associated with chronic kidney disease in African-Americans. The goal was to clarify earlier, inconsistent findings that the gene’s variants also could influence cardiovascular disease and mortality risk.
UNC, RTI International researchers assess US travelers’ knowledge of Zika virus, willingness to take hypothetical vaccine
July 2, 2018 A collaboration between researchers at the Gillings School, RTI International and UNC's School of Medicine has resulted in the first study to assess and compare United States travelers’ knowledge levels about the Zika virus across three regions, as well as their willingness to take a prophylactic Zika vaccine that currently is in development.
Barrington and team win research award for HIV/AIDS project in Guatemala
June 25, 2018 Central America’s first study to critically document the process of creating a community-based clinic for pre-exposure prophylaxis (PrEP) for gay men has been selected to receive the International Council of AIDS Service Organizations’ (ICASO) 2018 Robert Carr Research Award. Dr. Clare Barrington is the leader of the UNC research team on the collaborative project.
